000 | 01657 a2200457 4500 | ||
---|---|---|---|
005 | 20250514003657.0 | ||
264 | 0 | _c20010830 | |
008 | 200108s 0 0 eng d | ||
022 | _a1074-2484 | ||
024 | 7 |
_a10.1177/107424840100600104 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGilbert, T B | |
245 | 0 | 0 |
_aFenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology and therapeutics _cJan 2001 |
||
300 |
_a31-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAorta _xsurgery |
650 | 0 | 4 |
_aAortic Aneurysm, Abdominal _xsurgery |
650 | 0 | 4 |
_aCardiovascular Surgical Procedures _xadverse effects |
650 | 0 | 4 |
_aDopamine Agonists _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFenoldopam _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aKidney _xblood supply |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
650 | 0 | 4 |
_aRenal Insufficiency _xetiology |
650 | 0 | 4 | _aSurgical Instruments |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHasnain, J U | |
700 | 1 | _aFlinn, W R | |
700 | 1 | _aLilly, M P | |
700 | 1 | _aBenjamin, M E | |
773 | 0 |
_tJournal of cardiovascular pharmacology and therapeutics _gvol. 6 _gno. 1 _gp. 31-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/107424840100600104 _zAvailable from publisher's website |
999 |
_c11380681 _d11380681 |